Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Alkem Laboratories Ltd. ( (IN:ALKEM) ).
Alkem Laboratories Ltd. announced the cancellation of a scheduled Analyst/Institutional Investor Meeting that was to take place on September 9, 2025, in Mumbai. The cancellation of this meeting, which was intended to be a one-on-one session with FIL India Business & Research Services Pvt Ltd, may affect the company’s communication with investors and analysts, potentially influencing stakeholder perceptions and market positioning.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical formulations and active pharmaceutical ingredients. The company is known for its diverse range of products catering to various therapeutic segments and has a significant presence in both domestic and international markets.
Average Trading Volume: 16,410
Technical Sentiment Signal: Strong Buy
Current Market Cap: 638.1B INR
Learn more about ALKEM stock on TipRanks’ Stock Analysis page.